Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app boost breastfeeding rates in pakistan?

NCT ID NCT05590351

Knowledge-focused Sponsor: Aga Khan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile health app called First Diet to help new mothers in Pakistan improve breastfeeding and feeding practices for their infants. Researchers will enroll 300 pregnant women who have smartphones and follow them for one year after birth. The goal is to see if the app increases exclusive breastfeeding and proper introduction of solid foods, compared to standard in-person counseling.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mobile health application (First Diet)
What this could lead to
If effective, this app could help mothers in low-income areas improve infant feeding, potentially reducing malnutrition and child deaths.
What could go wrong
This is a relatively small trial in one region, and results may not apply elsewhere. The app relies on smartphone access, which may limit reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 48 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pregnant women in the third trimester at 36 +/- 1 week of gestation. 2. Planned to stay in their respective areas for at least 1 year after delivery 3. Planned to get the infant immunized from the respective FHC of the hospitals. 4. Have access to smart phones with internet connection. 5. Registered and planning to deliver to any of the Secondary Care Hospitals 6. Can read and write in local language (English and/or Urdu). 7. Consent to participate and remain in the study until 1 year of child age Exclusion Criteria: 1. High-risk including maternal neurological/heart/ autoimmune/renal disease, preeclampsia, placenta previa, multiple gestations (twins/triplets), fetal structural/genetic anomalies, fetal growth restrictions, and birth trauma/requiring NICU admission. 2. Women who plan to move to different location after delivery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malnutrition, child are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cachexia Child Nutrition Disorders hereditary endocrine growth disease Infant Nutrition Disorders nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malnutrition, child Malnutrition, infant

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Aga Khan University

    RECRUITING

    Karachi, Sindh, 74000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.